Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAOA | P21397 | 1/20 | 0.54 |
| ▸ | NOX1 | Q9Y5S8 | 1/20 | 0.50 |
| ▸ | KDM1A | O60341 | 1/20 | 0.50 |
| ▸ | BCHE | P06276 | 16/20 | 0.49 |
| ▸ | ACHE | P22303 | 3/20 | 0.46 |
| ▸ | GAA | P10253 | 1/20 | 0.42 |
| ▸ | MAPT | P10636 | 1/20 | 0.42 |
| ▸ | POLB | P06746 | 1/20 | 0.42 |
| ▸ | ATM | Q13315 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL627991 | 0.75 | BCHE (0.44) | MAOANOX1KDM1ABCHEACHE | |
| SCHEMBL22481364 | 0.74 | P2RX4 (0.62) | MAOABCHEGAAMAPT | |
| SCHEMBL20013876 | 0.74 | TTR (0.42) | MAOAKDM1AMAPTPOLB | |
| SCHEMBL10614342 | 0.72 | BCHE (0.47) | MAOANOX1KDM1ABCHEGAA | |
| SCHEMBL16261613 | 0.71 | L3MBTL1 (0.46) | MAPTPOLB | |
| SCHEMBL5915315 | 0.71 | MEN1 (0.48) | BCHEACHEMAPT | |
| SCHEMBL231247 | 0.70 | MAOA (1.00) | MAOANOX1KDM1ABCHEMAPT | |
| SCHEMBL29377505 | 0.70 | MAOA (1.00) | MAOANOX1KDM1ABCHEMAPT | |
| SCHEMBL1718054 | 0.69 | MAOA (0.64) | MAOANOX1KDM1ABCHEACHE | |
| SCHEMBL7699188 | 0.69 | KDM1A (0.55) | MAOAKDM1AMAPTPOLB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20170062842-A1 | TWO-ELECTRON REDOX ACTIVE MOLECULES WITH HIGH CAPACITY AND ENERGY DENSITY FOR ENERGY STORAGE APPLICATIONS | UCHICAGO ARGONNE, LLC | 2017-03-02 | — | — | US | claimed |
| US-10840531-B2 | Two-electron redox active molecules with high capacity and energy density for energy storage applications | UCHICAGO ARGONNE, LLC (US) | 2020-11-17 | — | — | US | disclosed |
| US-10840531-B2 | Two-electron redox active molecules with high capacity and energy density for energy storage applications | UCHICAGO ARGONNE, LLC (US) | 2020-11-17 | — | — | US | disclosed |
| US-20170062842-A1 | TWO-ELECTRON REDOX ACTIVE MOLECULES WITH HIGH CAPACITY AND ENERGY DENSITY FOR ENERGY STORAGE APPLICATIONS | UCHICAGO ARGONNE, LLC | 2017-03-02 | — | — | US | disclosed |
| US-20170062842-A1 | TWO-ELECTRON REDOX ACTIVE MOLECULES WITH HIGH CAPACITY AND ENERGY DENSITY FOR ENERGY STORAGE APPLICATIONS | UCHICAGO ARGONNE, LLC | 2017-03-02 | — | — | US | disclosed |
| US-20170062842-A1 | TWO-ELECTRON REDOX ACTIVE MOLECULES WITH HIGH CAPACITY AND ENERGY DENSITY FOR ENERGY STORAGE APPLICATIONS | UCHICAGO ARGONNE, LLC | 2017-03-02 | — | — | US | disclosed |
| EP-2641288-B1 | RECHARGEABLE METAL OR METAL-ION CELL | SOLVAY (BE) | 2016-08-17 | — | — | EP | disclosed |
| US-9203080-B2 | Rechargeable metal or metal-ion cell | SOLVAY SA (BE) | 2015-12-01 | — | — | US | disclosed |
| US-9203080-B2 | Rechargeable metal or metal-ion cell | SOLVAY SA (BE) | 2015-12-01 | — | — | US | disclosed |
| US-20130230771-A1 | Rechargeable metal or metal-ion cell | UNIVERSITE JOSEPH FOURIER (FR) | 2013-09-05 | — | — | US | disclosed |
| US-20130230771-A1 | Rechargeable metal or metal-ion cell | UNIVERSITE JOSEPH FOURIER (FR) | 2013-09-05 | — | — | US | disclosed |
| WO-2012066048-A1 | RECHARGEABLE METAL OR METAL-ION CELL | SOLVAY SA (BE) | 2012-05-24 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170062842-A1 | TWO-ELECTRON REDOX ACTIVE MOLECULES WITH HIGH CAPACITY AND ENERGY DENSITY FOR ENERGY STORAGE APPLICATIONS | CYP11B1, CYP11B2, ESR2 | MAOA 1614/4885NOX1 144/4885KDM1A 3208/4885 |
| US-10840531-B2 | Two-electron redox active molecules with high capacity and energy density for energy storage applications | CYP11B1, CYP11B2, ESR2 | MAOA 1614/4885NOX1 144/4885KDM1A 3208/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.